KRSNAA vs LALPATHLAB: Stock Comparison
DR. LAL PATH LABS is the larger company by market capitalisation. KRSNAA DIAGNOSTICS shows a lower P/E, while DR. LAL PATH LABS shows a higher ROE, a higher dividend yield and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
KRSNAA leads 5; LALPATHLAB leads 8 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | KRSNAA | LALPATHLAB |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Healthcare Service Provider | Healthcare Service Provider |
Price
| Metric | KRSNAA | LALPATHLAB |
|---|---|---|
| Live Price | ₹548.45 | ₹1,952.3 |
| Day Change | -0.51% | -0.46% |
| Volume | 23,523 | 4.52 L |
| 52-Week High | ₹852.15 | ₹3,313.3 |
| 52-Week Low | ₹515 | ₹1,272.6 |
| Distance from 52W High | -35.64% | -41.08% |
Valuation
| Metric | KRSNAA | LALPATHLAB |
|---|---|---|
| Market Cap | ₹1,779 Cr | ₹32,658 Cr |
| P/E Ratio | 18.26x | 60.35x |
| P/B Ratio | 1.81x | 13.04x |
| EPS | ₹5.1 | ₹9.9 |
| Book Value | ₹302.23 | ₹151.59 |
| Dividend Yield | 0.36% | 1% |
Growth
| Metric | KRSNAA | LALPATHLAB |
|---|---|---|
| Revenue Growth (TTM YoY) | 3.5% | 16.6% |
| EPS Growth (TTM YoY) | 102.1% | -15.4% |
| Qtr Sales Growth | 11.81% | -4.17% |
| Qtr Profit Growth | 4.62% | -2.7% |
Profitability & Leverage
| Metric | KRSNAA | LALPATHLAB |
|---|---|---|
| ROE | 10.35% | 20.06% |
| ROCE | 8.96% | 22.94% |
| Net Margin | 13.13% | 18.27% |
| Operating Margin | 21.33% | 25.04% |
| Debt to Equity | 0.55x | 0x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | KRSNAA | LALPATHLAB |
|---|---|---|
| Promoter Holding | 27.11% | 51.35%▼ 0.02 pp |
| FII Holding | 4.28%▲ 0.37 pp | 17.36%▲ 0.18 pp |
| DII Holding | 14.51%▲ 0.62 pp | 21.59%▲ 0.21 pp |
| Public Holding | 54.09%▼ 0.99 pp | 7.47%▼ 0.4 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: KRSNAA DIAGNOSTICS and DR. LAL PATH LABS.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.